Literature DB >> 14606062

Gene therapy for gastric cancer: a review.

Chao Zhang1, Zhan-Kui Liu.   

Abstract

Gastric cancer is common in China, and its early diagnosis and treatment are difficult. In recent years great progress has been achieved in gene therapy, and a wide array of gene therapy systems for gastric cancer has been investigated. The present article deals with the general principles of gene therapy and then focuses on how these principles may be applied to gastric cancer.

Entities:  

Mesh:

Year:  2003        PMID: 14606062      PMCID: PMC4656507          DOI: 10.3748/wjg.v9.i11.2390

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  71 in total

Review 1.  Gene repair and transposon-mediated gene therapy.

Authors:  Paul D Richardson; Lance B Augustin; Betsy T Kren; Clifford J Steer
Journal:  Stem Cells       Date:  2002       Impact factor: 6.277

Review 2.  Latest development in viral vectors for gene therapy.

Authors:  Kenneth Lundstrom
Journal:  Trends Biotechnol       Date:  2003-03       Impact factor: 19.536

3.  Reduction of tumorigenicity of SMMC-7721 hepatoma cells by vascular endothelial growth factor antisense gene therapy.

Authors:  Y C Tang; Y Li; G X Qian
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

4.  Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine.

Authors:  R G Crystal; E Hirschowitz; M Lieberman; J Daly; E Kazam; C Henschke; D Yankelevitz; N Kemeny; R Silverstein; A Ohwada; T Russi; A Mastrangeli; A Sanders; J Cooke; B G Harvey
Journal:  Hum Gene Ther       Date:  1997-05-20       Impact factor: 5.695

5.  Blockade of in vivo VEGF-mediated angiogenesis by antisense gene therapy: role of Flk-1 and Flt-1 receptors.

Authors:  Geneviève S Marchand; Nicolas Noiseux; Jean-François Tanguay; Martin G Sirois
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-01       Impact factor: 4.733

6.  Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy.

Authors:  F L Moolten
Journal:  Cancer Res       Date:  1986-10       Impact factor: 12.701

Review 7.  The role of oncology nurses in gene therapy.

Authors:  P T Rieger
Journal:  Lancet Oncol       Date:  2001-04       Impact factor: 41.316

8.  Local inflammation and devascularization--in vivo mechanisms of the "bystander effect" in VPC-mediated HSV-Tk/GCV gene therapy for human malignant glioma.

Authors:  F W Floeth; N Shand; H Bojar; H B Prisack; J Felsberg; E Neuen-Jacob; A Aulich; K J Burger; W J Bock; F Weber
Journal:  Cancer Gene Ther       Date:  2001-11       Impact factor: 5.987

9.  The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.

Authors:  S M Freeman; C N Abboud; K A Whartenby; C H Packman; D S Koeplin; F L Moolten; G N Abraham
Journal:  Cancer Res       Date:  1993-11-01       Impact factor: 12.701

10.  Effect of ursodeoxycholic acid on in vivo and in vitro toxic liver injury in rats.

Authors:  V Simko; S Michael
Journal:  Aliment Pharmacol Ther       Date:  1994-06       Impact factor: 8.171

View more
  3 in total

1.  Single-tube-genotyping of gastric cancer related SNPs by directly using whole blood and paper-dried blood as starting material.

Authors:  Huan Huang; Ying Bu; Guo-Hua Zhou
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

2.  Role of nucleostemin in growth regulation of gastric cancer, liver cancer and other malignancies.

Authors:  Si-Jin Liu; Zi-Wei Cai; Ya-Jun Liu; Mei-Yu Dong; Li-Qiu Sun; Guo-Fa Hu; Ying-Yun Wei; Wei-De Lao
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

3.  BAK overexpression mediates p53-independent apoptosis inducing effects on human gastric cancer cells.

Authors:  Qiang-Song Tong; Li-Duan Zheng; Liang Wang; Jun Liu; Wei Qian
Journal:  BMC Cancer       Date:  2004-07-12       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.